We have investigated the ability of the mitogen-activated protein kinase (MAPK) kinase MKK6 to activate different members of the p38 subfamily of MAPKs and found that some MKK6 mutants can efficiently activate p38␣ but not p38␥. In contrast, a constitutively active MKK6 mutant activated both p38 MAPK isoforms to similar extents. The same results were obtained upon coexpression in Xenopus oocytes and in vitro using either MKK6 immunoprecipitates from transfected cells or bacterially produced recombinant proteins. We also found that the preferential activation of p38␣ by MKK6 correlated with more efficient binding of MKK6 to p38␣ than to p38␥. Furthermore, increasing concentrations of constitutively active MKK6 differentially activated either p38␣ alone (low MKK6 activity) or both p38␣ and p38␥ (high MKK6 activity), both in vitro and in injected oocytes. The determinants for selectivity are located at the carboxyl-terminal lobe of p38 MAPKs but do not correspond to the activation loop or common docking sequences. We also showed that different stimuli can induce different levels of endogenous MKK6 activity that correlate with differential activation of p38 MAPKs. Our results suggest that the level of MKK6 activity triggered by a given stimulus may determine the pattern of downstream p38 MAPK activation in the particular response.
We have investigated the ability of the mitogen-activated protein kinase (MAPK) kinase MKK6 to activate different members of the p38 subfamily of MAPKs and found that some MKK6 mutants can efficiently activate p38␣ but not p38␥. In contrast, a constitutively active MKK6 mutant activated both p38 MAPK isoforms to similar extents. The same results were obtained upon coexpression in Xenopus oocytes and in vitro using either MKK6 immunoprecipitates from transfected cells or bacterially produced recombinant proteins. We also found that the preferential activation of p38␣ by MKK6 correlated with more efficient binding of MKK6 to p38␣ than to p38␥. Furthermore, increasing concentrations of constitutively active MKK6 differentially activated either p38␣ alone (low MKK6 activity) or both p38␣ and p38␥ (high MKK6 activity), both in vitro and in injected oocytes. The determinants for selectivity are located at the carboxyl-terminal lobe of p38 MAPKs but do not correspond to the activation loop or common docking sequences. We also showed that different stimuli can induce different levels of endogenous MKK6 activity that correlate with differential activation of p38 MAPKs. Our results suggest that the level of MKK6 activity triggered by a given stimulus may determine the pattern of downstream p38 MAPK activation in the particular response.
Cellular responses to many external stimuli involve the activation of several types of mitogen-activated protein kinase (MAPK) 1 signaling pathways. Three major subfamilies of MAPKs have been described in vertebrates. The p42/p44 ERK MAPKs are mainly activated by growth factors and other stimuli involved in cell proliferation and differentiation processes. In contrast, the SAPK/JNK and the p38 MAPKs are strongly activated in response to stress conditions and proinflammatory cytokines. Despite the diversity in function and upstream signaling events, MAPKs are always activated by a highly conserved mechanism that involves phosphorylation on both a Thr and a Tyr residue catalyzed by a MAPK kinase. The phosphorylation motif Thr-Xaa-Tyr is located in the so called activation loop or T loop whose amino acid sequence varies among different MAPK subfamilies. Accordingly, there are different activating MAPK kinases that in most cases are specific for each subgroup of MAPKs (reviewed by Refs. [1] [2] [3] The p38 MAPK subfamily plays important roles in cytokine production and the stress response (reviewed by Ref. 4) . Recent reports have also demonstrated additional functions for p38 MAPKs, for example, in the inhibition of cell cycle progression, in developmental processes such as egg polarity and wing morphogenesis in Drosophila, and in the differentiation of several vertebrate cell types including neurons, adipocytes and myoblasts (reviewed in Ref. 5) . Four p38 MAPKs have been cloned so far in higher eukaryotes: p38␣/XMpk2/CSBP (6 -9), p38␤/ p38␤2 (10, 11) , p38␥/SAPK3/ERK6 (12) (13) (14) , and p38␦/SAPK4 (15) (16) (17) . These four proteins are 60 -70% identical in their amino acid sequence and are all activated by the MAPK kinase MKK6 (15, 18) . Another MAPK kinase, MKK3, has been shown to phosphorylate and activate p38␣, p38␥, and p38␦ but not p38␤2 (11, 19) . Moreover, p38␣ can also be activated in vitro by MKK4, one of the JNK/SAPK activators (20 -22) , and MKK4 Ϫ/Ϫ fibroblasts but not embryonic stem cells exhibit defects in p38 MAPK phosphorylation (23) . p38 MAPK isoforms also differ in their susceptibility to inhibition by pyridinyl imidazoles that can inhibit p38␣ and p38␤ at submicromolar concentrations (24) but have no inhibitory effect on p38␥ and p38␦ (25) . Substrates of p38 MAPKs include the protein kinases MAP-KAPK-2/3, MNK1, MSK, and PRAK and several transcription factors such as ATF-2, c/EBPs, and MEF2C (reviewed in Ref. 25) . Some of these substrates are preferentially phosphorylated in vitro by one or more p38 MAPK isoforms, suggesting that these enzymes may have both overlapping and highly specific functions. Consistent with this possibility, some extracellular stimuli can selectively activate specific p38 MAPK isoforms (26, 27) . Moreover, targeted gene disruption in mice has recently shown that p38␣ is essential only for placenta organogenesis, despite being ubiquitously expressed in the embryo (28) . This suggests that p38␣ function might be redundant for other aspects of mammalian embryonic development.
We are interested in the differential regulation of p38 MAPK isoforms. Here we show that p38␣ can be efficiently activated by low levels of MKK6 activity, whereas other p38 isoforms are only activated by high levels of MKK6 activity. The selectivity probably depends on sequences located at the carboxyl-terminal lobe of p38 MAPKs, which do not correspond to motifs previously proposed to be important for the recognition of MAPKs by MAPK kinases. Our results suggest a mechanism for the specific activation of p38 MAPKs depending on the level of MKK6 activity triggered by a given stimulus.
EXPERIMENTAL PROCEDURES
DNA Constructs and Mutagenesis-To produce recombinant MalE-MKK6, the human MKK6/SKK3 cDNA (29) was cloned into the pMalc2 vector (New England Biolabs) as a PCR product obtained using a 5Ј oligonucleotide that created an XbaI site immediately downstream of the ATG and a 3Ј oligonucleotide that introduced a HindIII site downstream of the stop codon. A construct to produce recombinant His-* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
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MKK6 was generated by subcloning into pET15 (Novagen) the PCR product obtained using a 5Ј oligonucleotide that created an NcoI site at the ATG and at the same time replaced amino acid number 3 of MKK6 by 5 His residues and a 3Ј oligonucleotide that introduced an XhoI site downstream of the stop codon. For expression in Xenopus oocytes and mammalian cells, MKK6 was cloned into the vectors FTX5 (30) and pEFmlink (provided by Caroline Hill and Richard Treisman, Imperial Cancer Research Fund, London, UK), respectively. In both cases, MKK6 was amplified by PCR using oligonucleotides that created an NcoI site at the ATG and an XhoI downstream of the stop codon. The mutants MKK6-DD, MKK6-AA, MKK6-K/R, and MKK6-D/A (see Fig.  1 ) were generated by PCR using the above vectors as templates for the QuikChange site-directed mutagenesis kit (Stratagene). Mutations were confirmed by DNA sequencing.
The Xenopus p38␣/XMpk2 cDNA (7) was amplified by PCR using oligonucleotides that introduced two BglII sites flanking the open reading frame. The PCR product was digested with BglII and subcloned into BglII-digested pSP64T (Promega) for expression in Xenopus oocytes and BamHI-digested pSG5 (Stratagene) for mammalian cells. The construct to express MalE-XMpk2/p38␣ in bacteria has been previously described (20) . The mutant p38␣-K54R was generated by PCR using the QuikChange mutagenesis kit. A rat p38␥/SAPK3 cDNA cloned in the vectors pSG5 and pGEX4T-1 (18) was provided by Michel Goedert (Medical Research Council-Laboratory of Molecular Biology, Cambridge, UK) and was subcloned into FTX5 as an EcoRI fragment. The constructs to express human p38␣, p38␤2, and p38␦ as recombinant proteins fused to GST (15, 31) were provided by Philip Cohen and associates (Medical Research Council, Dundee, UK). A plasmid to express GST-ATF-2 (amino acids 19 -96) (32) was provided by Gunvanti Patel and Nic Jones (Imperial Cancer Research Fund, London, UK).
The mutants p38␥(AL-p38␣), p38␥(CD-p38␣), and p38␥(AL/CDp38␣) were generated by replacing amino acids 177-189 (activation loop, as indicated by "AL" above) and/or 313-321 (common docking, as indicated by "CD" above) of p38␥ by the corresponding sequences of p38␣ (HTDDEMTGYVATR and QYHDPDDEP, respectively) using the QuikChange mutagenesis kit. The fusions between p38␣ and p38␥ were prepared by overlapping PCR using as a linker the sequence MGADL (amino acids 109 -113 of p38␣). For the N-p38␣/C-p38␥ chimera, amino acids 1-108 of p38␣ were fused to the sequence MGADL followed by amino acids 117-367 of p38␥. For N-p38␥/C-p38␣, amino acids 1-111 of p38␥ were fused to MGADL followed by amino acids 114 -360 of p38␣.
For protein purification, MalE or GST constructs were transformed into Escherichia coli BL-21 (DE3), and their expression was induced with isopropyl-1-thio-␤-D-galactopyranoside. Recombinant proteins were purified on amylose beads (MalE fusions) or glutathione beads (GST fusions) as described (33) .
Antibodies-The anti-p38␣ antiserum used for immunoprecipitation was prepared against the carboxyl-terminal 14 amino acids of Xenopus p38␣/XMpk2 as described previously (7) . For immunoblotting we used an anti-p38␣ antibody (C-20) purchased from Santa Cruz. The anti-SAPK3/p38␥ and anti-MKK6 antisera were prepared in rabbits by immunization with the bacterially produced GST-SAPK3 and MalE-MKK6 recombinant proteins described above, respectively. The overexpressed, Myc-tagged MKK6 and p38␥ proteins were immunoprecipitated using the 9E10 monoclonal antibody. Anti-phospho-p38 and antiphospho-MKK6/MKK3 antibodies that specifically recognize p38 MAPKs phosphorylated both on the Thr and Tyr residues in the activation loop and the phosphorylated form of MKK3 and MKK6, respectively, were purchased from New England Biolabs. Anti-polyhistidine antibody was purchased from Sigma. Anti-MalE and anti-GST antibodies were provided by Julian Gannon (Imperial Cancer Research Fund, South Mimms, UK).
Cell Culture and Transfection-HEK293, HeLa and NIH3T3 cells were routinely grown at 37°C in Dulbecco's modified Eagle's medium containing 10% fetal calf serum, penicillin and streptomycin, 2 mM glutamine under an atmosphere of 5% CO 2 . PC12 cells were grown in Dulbecco's modified Eagle's medium containing 6% fetal calf serum, 6% horse serum, penicillin, streptomycin, 2 mM glutamine, and 10 mM Hepes. Plates were about 70% confluent before stimulation.
HEK293 cells were transiently transfected (calcium phosphate method) using 5-10 g of plasmid DNA/10-cm plate of 70 -80% confluent cells. The cells were then incubated for 36 -48 h, stimulated with UV for 30 s (using a Stratalinker set at 80% of potency) and incubated for a further 30 min at 37°C before lysis.
Expression in Xenopus Oocytes-Stage VI Xenopus oocytes were injected with 50 nl of capped mRNAs (usually 10 ng unless otherwise indicated) prepared from linearized pSP64T and FTX5 constructs using the MEGAscript in vitro transcription kit (Ambion). Injected oocytes were incubated for the indicated times and then frozen in dry ice. For preparation of lysates, oocytes were homogenized in 10 l/oocyte of ice-cold H1 kinase buffer (80 mM sodium ␤-glycerophosphate, pH 7.5, 20 mM EGTA, 15 mM MgCl 2 , 1 mM dithiothreitol, 1 mM Pefabloc, and 1 g/ml each of leupeptin and aprotinin). Lysates were centrifuged for 10 min at 10,000 ϫ g, and 5 l of the cleared supernatant was used for immunoblot analysis. The activity of the proteins expressed in oocytes was assayed by immunoprecipitation of 4 -5 oocytes followed by in vitro kinase assay.
In Vitro Kinase Assay-Kinase assays were carried out in a final volume of 12 l in buffer A (50 mM Tris-HCl, pH 7.5, 10 mM MgCl 2 , 2 M microcystin, and 10 M ATP with 2 Ci of [␥-
32 P]ATP, 3000 Ci/mmol) containing 0.8 -1 g of substrate for 30 min at 30°C. The reaction was stopped by the addition of sample loading buffer and boiling for 3 min. Proteins were resolved by SDS-PAGE and detected by autoradiography.
Immunoprecipitation and Immunoblotting-Cells were washed with cold PBS and lysed (0.5 ml/10 cm plate) in IP buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% Nonidet P-40, 5 mM EDTA, 5 mM EGTA, 20 mM NaF, 0.1 mM sodium orthovanadate, 1 mM Pefabloc, 2.5 mM benzamidine, 50 nM calyculin A, and 10 g/ml of leupeptin and aprotinin). Lysates were transferred to ice-cold microcentrifuge tubes, vortexed, incubated for 10 min on ice, and centrifuged for 10 min at 10,000 ϫ g to remove insoluble material. Lysates (200 g) were incubated with 2-3 l of antisera for 60 min at 4°C, followed by incubation with 10 l of protein A-Sepharose (Amersham Pharmacia Biotech) for a further 30 min. All incubations and centrifugations were carried out at 4°C. Immunoprecipitates were washed three times with IP buffer and once with kinase buffer (50 mM Tris-HCl, pH 7.5, 10 mM magnesium acetate, 1 mM dithiothreitol, 0.1 mM sodium orthovanadate, and 25 nM calyculin A). Kinase assays were incubated for 20 min at 30°C in 15 l of kinase buffer containing 100 M ATP (2-5 Ci of [␥-32 P]ATP, 3000 Ci/mmol) and 1 g of substrate. The reaction was stopped by adding the sample loading buffer and boiling the samples for 3 min. Proteins were resolved by electrophoresis in 17.5% PAGE (34) and detected by autoradiography.
For immunoprecipitation of the endogenous MKK6, 350 g of lysates were incubated with 3 l of anti-MKK6 antiserum for 1.5 h at 4°C on a rotating wheel. Protein A-Sepharose (15 l) was then added, and the samples were rocked at 4°C for 1 h. The immunoprecipitates were collected by centrifugation (500 ϫ g, 1 min), washed four times in immunoprecipitation buffer, and washed once in kinase buffer. The kinase assay was performed as reported above.
For immunoblotting, proteins (25-50 g of lysate) were separated by SDS-PAGE and transferred to nitrocellulose (BA85, Schleicher & Schuell) using a semi-dry blotting apparatus. The membranes were blocked in TTBS (25 mM Tris, pH 8, 150 mM NaCl, 0.05% Tween-20) containing 4% nonfat milk for 1 h at room temperature. Primary antibodies were incubated in TTBS containing 1% milk (except for the anti-phospho-MKK6 antibody which was incubated in 3% bovine serum albumin) and binding was detected by horseradish peroxidase-coupled secondary antibodies (Dako) followed by ECL detection (Amersham Pharmacia Biotech).
Pull-down Experiments-MalE-MKK6 recombinant proteins (2 g) were bound to amylose beads (10 l) for 1 h at 4°C in PBS. The beads were washed three times in PBS and once in IP buffer and then mixed with 500 g of HEK293 lysates overexpressing either p38␣ or p38␥. Binding was allowed to proceed for 2-3 h at 4°C. After washing three times in IP buffer, the material bound to the recombinant proteins was separated by SDS-PAGE, and the presence of p38␣ and p38␥ was detected by immunoblotting.
For the in vitro binding experiments, GST-or MalE-fusion proteins (1-1.5 g) were incubated with His-MKK6 (0.6 -0.8 g) in a final volume of 200 l of IP buffer, at room temperature on the rotating wheel. After 30 min, 10 l of glutathione-Sepharose (Amersham Pharmacia Biotech) or amylose beads (New England Biolabs) which have been preincubated in PBS containing bovine serum albumin (2 mg/ml) for 2 h at room temperature were added and incubated for 90 min at 4°C on the rotating wheel. The beads were collected by centrifugation (500 ϫ g, 1 min), washed four times in IP buffer, and analyzed by SDS-PAGE. The presence of bead-bound His-MKK6 was detected by immunoblotting using the anti-MKK6 and anti-polyHistidine antibodies for the GST and MalE pull-downs, respectively.
RESULTS

Differential Activation of p38␣ and p38␥ by MKK6 Mutants-
The ability of the MAPK kinase MKK6 to activate the two p38 MAPK family members p38␣ and p38␥ was investigated upon co-expression in Xenopus oocytes. For this purpose, oocytes were first injected with mRNAs encoding either wild type MKK6 or the mutants MKK6-K/R (Lys-82 in the ATP binding pocket mutated to Arg), MKK6-DD, or MKK6-AA (the two phosphorylation sites in the activation loop Ser-207 and Thr-211 changed to Glu or Ala, respectively) (Fig. 1) . After overnight incubation to allow for expression of the MKK6 proteins, mRNAs encoding p38␣ or p38␥ were injected, and samples were taken 4 and 10 h later. Oocytes were lysed, and the activity of p38␣ and p38␥ was assayed by immune complex kinase assay, using MBP as an exogenous substrate. We found that p38␥ activity was stimulated only by co-injection with the constitutively active MKK6-DD mutant (Fig. 2, lower panel,  lanes 4 and 9) . Surprisingly, p38␣ was activated by co-injection with all four MKK6 mutants, including MKK6-K/R, albeit MKK6-DD showed a faster kinetic of activation than the other MKK6 proteins ( Fig. 2A, upper panel, lanes 1-5) . However, the extent of p38␣ activation by the four MKK6 proteins was very similar after co-expression for 10 h (Fig. 2, upper panel, lanes  7-10) .
Phosphorylation of p38␣ and p38␥ by MKK6 Mutants in Vitro-We next used a different system to test the ability of different MKK6 mutants to phosphorylate and activate p38␣. Myc-tagged MKK6 mutants were transiently transfected into HEK293 cells that were then either left unstimulated or stimulated with UV radiation, a potent activator of the p38 MAPK pathway (10, 18, 35) . The expressed MKK6 proteins (Fig. 3A) were then immunoprecipitated, and their kinase activity was assayed using bacterially produced p38␣ or p38␥ as a substrate (Fig. 3B) . p38␥ was phosphorylated both by the constitutively active MKK6-DD mutant and by the wild type MKK6; the latter more strongly after UV-stimulation (Fig. 3B, lower panel,  lanes 2, 5, and 6 ). In contrast, p38␣ was phosphorylated by all MKK6 mutants, even when recovered from non-UV-stimulated cells (Fig. 3B, upper panel, lanes 1-8) , except by MKK6-D/A (Fig. 3B, lanes 9 and 10; see below) . The same results were observed when the MKK6 proteins were immunoprecipitated from mRNA-injected Xenopus oocytes, and their kinase activity was assayed on recombinant p38␣ and p38␥; all MKK6 mutants phosphorylated p38␣, whereas p38␥ was only efficiently phosphorylated by the constitutively active MKK6-DD mutant (data not shown).
We also carried out this experiment using purified MKK6 mutant proteins expressed in E. coli (Fig. 4) . In this case recombinant MKK6 mutants were incubated in vitro with recombinant p38␣ or p38␥ in the presence of [␥-
32 P]ATP. Phosphorylated proteins were resolved by SDS-PAGE and visualized by autoradiography. As in previous experiments p38␥ was strongly phosphorylated by the MKK6-DD mutant (Fig. 4, lane  10) and more weakly by MKK6 wild type or the AA mutant (Fig. 4, lanes 8 and 11) . However, p38␣ was phosphorylated by all the recombinant MKK6 mutant proteins (Fig. 4, lanes 2-5) except by MKK6-D/A (Fig. 4, lane 6) . This confirms the results obtained with MKK6 immunoprecipitated from transfected HEK293 cells or mRNA-injected Xenopus oocytes. In all cases phosphorylation of recombinant p38␣ and p38␥ correlated with an increase in the kinase activity of the proteins, measured by their ability to phosphorylate the substrates GST-ATF2 and MBP when these were included in the reaction mixture (see Figs. 7A, 8, and 9) .
Association of MKK6 with p38␣ but Not with p38␥-One possibility to explain the different susceptibility of p38␣ and p38␥ to phosphorylation by MKK6 mutants could be that the two p38 MAPKs have different affinities for the MKK6 activator. To test this hypothesis recombinant MalE-MKK6 or MalE alone were bound to amylose beads and mixed with extracts of HEK293 cells overexpressing either p38␣ or p38␥. Binding of the p38 MAPKs to the beads was visualized by immunoblotting (Fig. 5A ). MalE-MKK6 was able to bind p38␣ from unstimulated or UV-stimulated cells much more efficiently than MalE alone (Fig. 5A, upper panel, compare lanes 3 and 4 with lanes 5  and 6) , indicating that p38␣ specifically associates with MKK6. In contrast, p38␥ was not detected in MalE-MKK6 pull-downs (Fig. 5A, lower panel, lanes 5 and 6) . When the same experi- ment was carried out using different MKK6 mutants, we found that p38␣ could associate with all mutants to a similar extent, whereas p38␥ was never detected in MalE-MKK6 pull-downs (Fig. 5B) . Moreover, we could detect in vitro association between purified MKK6 and GST-p38␣ proteins (Fig. 5C, lane 2) but not between MKK6 and GST-p38␥ proteins (Fig. 5C, lane  1) . These results indicate that complex formation between MKK6 and p38␣ does not require additional proteins present in HEK293 cell extracts and that there is an intrinsic difference between p38␣ and p38␥ in their ability to form stable complexes with MKK6.
Impaired Phosphorylation of p38␣-K54R by MKK6 -The ability of MKK6-K/R to induce phosphorylation of p38␣ in vitro suggested that this mutant has some residual kinase activity or, alternatively, that it was able to induce p38␣ autophosphorylation. Because MKK6 and p38␣ can form stable complexes, we tested the possibility that MKK6 might induce p38␣ autophosphorylation. For this purpose we compared the wild type p38␣ with the mutant p38␣-K54R (Lys-54 mutated to Arg), which is expected to have impaired kinase activity. Recombinant p38␣-K54R was phosphorylated by all MKK6 mutants in vitro, although to a significantly lesser extent than the wild type p38␣ (Fig. 6A, upper panel, compare lanes 2-5 with lanes  7-10) . Similar results were obtained using an antibody that specifically recognizes the dual phosphorylated form of p38 MAPKs (Fig. 6A, middle panel) . This suggests that p38␣ might autophosphorylate in a MKK6-dependent manner. In contrast to MKK6-K/R, the mutant MKK6-D/A (Asp-197 mutated to Ala) was unable to phosphorylate p38␣ both upon co-expression in Xenopus oocytes (data not shown) and in vitro using MKK6-D/A recombinant protein or immunoprecipitates from HEK293 transfected cells (Figs. 3 and 4) . However, MKK6-D/A was still able to bind p38␣ with efficiency similar to that of the other MKK6 mutants (data not shown). These results suggest that MKK6-D/A is catalytically inactive, whereas the MKK6-K/R mutant probably has some low activity. Similar differences in activity between K/R and D/A mutants have been also reported for other protein kinases (36) . Thus, if MKK6 induces p38␣ autophosphorylation, this requires not only binding of the two proteins but also some prior phosphorylation by MKK6.
To investigate further the possibility that MKK6 might induce autophosphorylation of p38␣, we used the p38␣ inhibitor SB203580. We found that preincubation with SB203580 did not affect the ability of MKK6 to induce phosphorylation of p38␣ (Fig. 6C, compare lanes 1-4 with lanes 5-8) . In contrast, SB203580 blocked in the same experiment the ability of MKK6-activated p38␣ to phosphorylate the exogenous substrate ATF-2 (Fig. 6B, lanes 9 -11) . These results suggest that less efficient phosphorylation by MKK6, rather that the contribution of p38␣ autophosphorylation, might account for the reduced phosphorylation of the p38␣-K54R mutant incubated with MKK6. Consistent with this possibility, we also found that the K54R mutation significantly reduced the ability of p38␣ to associate with MKK6 in vitro. (Fig. 6C, lanes 2 and 3) . Taken together, the results support the idea that the stability of the Lysates from HEK293 cells transfected with p38␣ or p38␥ were used in pull-down experiments. A, lysates prepared from transfected cells were treated or not with UV, and the lysates were used for pull-down experiments using either MalE alone or MalE-MKK6 prebound to beads. Binding of p38␣ and p38␥ to the recombinant proteins was detected by immunoblot. B, lysates prepared from transfected cells were used in pull-down experiments with either MalE alone or different MalE-MKK6 mutant proteins as described above. C, purified GST-p38␣ and GST-p38␥ (1.5 g) were incubated with purified His-MKK6 (0.8 g) and then recovered on GSH-Sepharose beads. The proteins bound to the beads were analyzed by immunoblotting using anti-GST and anti-MKK6 antibodies. complex between MKK6 and p38␣ correlates with the efficient phosphorylation and activation of p38␣.
Differential Activation of p38 Isoforms by Increasing Concentrations of MKK6 -The differential susceptibility of p38␣ and p38␥ to phosphorylation and activation by the MKK6 mutants could be reflecting that different amounts of MKK6 activity are needed to activate these two p38 MAPKs. To test this possibility we performed an in vitro kinase reaction in which a fixed amount of bacterially produced p38␣ or p38␥ was incubated with increasing amounts of recombinant MKK6-DD. We found that the level of p38␣ phosphorylation in the reaction was independent of the amount of MKK6-DD over a 50-fold range (Fig. 7A, left panel) . In contrast, the phosphorylation of p38␥ increased in parallel with the amount of activator present in the reaction (Fig. 7A, right panel) . Exactly the same behavior was observed when the activities of the two protein kinases were evaluated on the substrate ATF-2; p38␣ was maximally activated at low doses of MKK6-DD (Fig. 7A, lanes 5-8) , whereas p38␥ activity increased gradually and required higher doses of MKK6-DD for maximal activation (Fig. 7A, lanes  13-16) .
We next investigated whether the differential activation of the two p38 MAPKs with respect to different amounts of activator could also be reproduced in intact cells. For this experiment, we co-injected into Xenopus oocytes a fixed amount of either p38␣ or p38␥ mRNAs with increasing amounts of MKK6-DD mRNA. After 10 h of incubation, to allow for expression of the proteins, p38␣ and p38␥ were immunoprecipitated from the oocyte lysates, and their kinase activities were measured using GST-ATF2 as an in vitro substrate. As shown in Fig.  7B , p38␥ activity was stimulated proportionally to the amount of MKK6-DD expressed in the oocytes (Fig. 7B, right panels) ; however, p38␣ was highly activated by low doses of MKK6-DD, and increasing the amount of activator expressed did not lead to further stimulation of p38␣ activity (Fig. 7B, left panels) .
We also investigated the response of other p38 isoforms to different concentrations of MKK6 and found that the phosphorylation of both p38␤ and p38␦ increased in parallel with the amount of activator present in the reaction, as in the case of p38␥ (Fig. 8) . The level of p38 phosphorylation also correlated with its kinase activity on MBP, although the recombinant GST-p38␤ showed significant constitutive activity in the absence of MKK6 phosphorylation (Fig. 8) .
The Activation Loop and Common Docking Sequences Are Not Responsible for the Selective Activation of p38␣ by Low
Concentrations of MKK6 -We investigated the possible contribution to the selective activation of p38 isoforms by MKK6 of two sequences that may be important, in some cases, for the activation of MAPKs. One is the activation loop or T loop, which has been reported to contribute to the differential activation of p38␣ and p38␤2 by MKK3 (19) . The other one is the common docking domain, which includes negatively charged amino acids important for the interaction of MAPKs with docking sites in both their activators and substrates (37) . In each of these regions, four amino acids are different between p38␣ and p38␥. We prepared mutant proteins in which the activation loop or the common docking sequences of p38␥ were replaced by the corresponding sequences of p38␣. However, these two mutants behaved like p38␥ in their ability to be phosphorylated and activated by different concentrations of MKK6 (Fig. 9A, lanes   FIG. 6. Phosphorylation of p38␣-K54R by MKK6 mutants. A, MalE-p38␣ and MalE-p38␣-K54R were incubated alone or with MalE-MKK6 mutants, in the presence of [␥- Proteins were resolved by SDS-PAGE and detected by autoradiography. GST-ATF2 was also included in the samples of lanes 9 -11. C, purified MalE-p38␣ and MalE-p38␣-K54R (1 g) were incubated with purified His-MKK6 (0.6 g) and then recovered on amylose beads. The proteins bound to the beads were analyzed by immunoblotting using anti-MalE and anti-polyHistidine antibodies. wt, wild type. 4 and 9 -12 ) or in the presence of GST-ATF-2 (1 g, lanes 5-8 and 13-16) . Phosphorylated proteins were resolved by SDS-PAGE and detected by autoradiography. B, p38␣ and p38␥ mRNAs were co-injected into oocytes with different amounts of MKK6-DD mRNA (0.5, 2, and 10 ng). After 10 h of incubation, p38␣ and p38␥ were immunoprecipitated from oocyte lysates and their kinase activities assayed using GST-ATF2 as a substrate (bottom panels). The expression levels in oocytes of the proteins MKK6-DD (top panels), p38␣ and p38␥ (middle panels) were analyzed by immunoblot. (Fig. 9B) . Similar results were observed when both sequences were simultaneously swapped in p38␥ (Fig. 9C, lanes 9 -12) . These results suggest that the activation loop and common docking sequences are not responsible for the differential activation by MKK6 of p38␣ versus other p38 isoforms.
-16) as well as to associate with MKK6 in vitro
We also generated chimeric molecules between p38␣ and p38␥. When the amino-terminal lobe of p38␣ was fused to the carboxyl-terminal lobe of p38␥, the phosphorylation and activation of the chimeric protein by MKK6 was similar to p38␥ (Fig. 9C, compare lanes 5-8 with lanes 13-16) . However, when we fused the amino-terminal lobe of p38␥ to the carboxylterminal lobe of p38␣, the chimeric protein was more similar to p38␣ than to p38␥ in their response to MKK6 (Fig. 9C, compare  lanes 1-4 with lanes 17-20) . The differential activation also correlated with differences between the chimeric molecules in their ability to bind MKK6, although these were not as marked as between the p38␣ and p38␥ isoforms (Fig. 9D) . These results suggest that the determinants for the selective activation of p38␣ by low concentrations of MKK6 are likely to be located in the carboxyl-terminal lobe of p38 MAPKs.
Differential Stimulation of p38 MAPK Signaling in Response to Various Stimuli-Our results indicate that different levels of MKK6 can trigger the activation of different p38 MAPK isoforms. We investigated whether different stimuli could induce different levels of MKK6 activity in intact cells. By immunoblot with antibodies that specifically recognize the phosphorylated and active form of MKK6 and MKK3, we found differences both in the types and in the levels of p38 activators depending not only on the nature of the extracellular stimuli but also on the cell type (Fig. 10A, upper panel) . The lower bands recognized by the anti-phospho-MKK6/MMK3 antibodies correspond to MKK6 (Fig. 10A , lower panel, and data not shown), whereas the middle and upper doublets appear to comigrate with MKK3 and MKK4 respectively (data not shown). We confirmed that the intensity of the signal in immunoblots using the phosphospecific antibodies correlated with different activities of MKK6 in immunoprecipitates (Fig. 10B) . Moreover, the induction of different levels of MKK6 (and other p38 activators) by different stimuli correlated with the differential phosphorylation of endogenous p38 isoforms (Fig. 10C) . Low levels of endogenous MKK6 activity correlated with phosphorylation of p38␣ alone (Fig. 10C, lane 6) , whereas both p38␣ and at least another p38 isoform (most likely p38␥; data not shown) were phosphorylated when high levels of MKK6 activity were present in the cells (Fig. 10C, lanes 2-5 and 9 ).
DISCUSSION
The p38 subfamily of MAPKs is composed of four members: p38␣, p38␤, p38␥, and p38␦ (see the Introduction). Alternatively spliced forms of p38␣ and p38␤ have also been described (8, 11, 38, 39) This variety of p38 MAPKs probably allows greater versatility in the use of this signaling pathway for different cell-and stimulus-specific responses. An additional level of versatility comes from the overlapping but differing (1 g). Phosphorylated proteins were resolved by SDS-PAGE and detected by autoradiography. B and D, purified GST fusion proteins of the same p38␣ and p38␥ mutants (1 g) were incubated with purified His-MKK6 (0.8 g) and then recovered on GSH-Sepharose beads. The proteins bound to the beads were analyzed by immunoblotting using anti-GST and anti-MKK6 antibodies. See "Experimental Procedures" for details of the different mutants.
substrate specificity of each p38 MAPK (11, 25) . The MAPK kinase MKK6 has been shown to be a major p38 MAPK activator under many conditions (11, 15, 29, 35, 40) . In this report, we present evidence that MKK6 does not activate all p38 MAPK isoforms with the same efficiency suggesting a mechanism for the differential activation of p38 MAPKs within the same cell.
We found that p38␣ can be activated by unphosphorylated MKK6 proteins that should have reduced kinase activity (MKK6 wt and MKK6-AA) and even by the mutant MKK6-K/R, which, based on the same mutation in other protein kinases, is expected to be catalytically inactive (41, 42) or have only residual kinase activity (43) (44) (45) . In contrast, p38␥ was only activated by constitutively active MKK6 (MKK6-DD). The differential behavior of the MKK6-K/R and MKK6-AA mutants depending on whether the substrate was p38␣ or p38␥ was surprising. Previous reports have shown that equivalent MKK6 mutations were unable to activate p38␣ in co-transfection experiments or had a dominant negative effect on p38␣ activation induced for example by sorbitol treatment (35, 46) . This apparent discrepancy may be due to differences in the expression levels of the proteins or to the mutation of different residues in MKK6 (Ala-82 in Ref. 35 ; Ala-207 and Leu-211 in Ref. 46 ). For example, Brill et al. (45) have described differences in the activity of the yeast MAPK kinase Ste7 when the Lys in the Gly-rich ATP binding loop was mutated to either Arg or Ala. We have also confirmed that the UV-induced activation of p38␣ is reduced when p38␣ is co-transfected with MKK6-AA in comparison with either p38␣ alone or p38␣ co-transfected with MKK6 wt. However in the same experiments, the expression of MKK6-AA alone (in the absence of UV stimulation) increases the activity of the co-transfected p38␣. 2 What could be the mechanisms underlying differential phosphorylation of p38 MAPKs by the MKK6 mutants? It has been proposed that the specific interaction with MAPK kinases may be important for the regulation of mammalian MAPKs (46) . An explanation for the differential activation of p38␣ and p38␥ could be that they have differences in any parameter, such as affinity or off rates that may affect the stability of their association with MKK6. Indeed, using purified proteins we detected direct association between MKK6 and p38␣, but we could not detect binding to p38␥ under the same conditions. This indicates that MKK6 can form more stable complexes with p38␣ than with p38␥. However, other mechanisms may also be involved, because the MKK6-DD mutant can phosphorylate and activate p38␣ and p38␥ equally well, but we were unable to detect stable association of p38␥ with MKK6-DD in pull-down experiments.
An essential requirement for MAPK activation is the phosphorylation of two residues in the activation loop catalyzed by MAPK kinases (47, 48) . However, stimulation of autophosphorylation has also been proposed as an alternative mechanism for MAPK activation (49) . This is less efficient than phosphorylation by MAPK kinase, but it might be also functional in vivo, and it is conceivable that MAPK activation could involve in some cases a combination of the two mechanisms. The observation that the p38␣-K54R mutant is phosphorylated by all the MKK6 mutants to a significantly lesser extent than the wild type p38␣ protein suggests that MKK6 might induce autophosphorylation of p38␣. However, we found that the p38␣ inhibitor SB 203580 was unable to reduce the MKK6-induced phosphorylation of p38␣. This result together with the observation that p38␣-K54R does not bind MKK6 with the same efficiency as the wild type p38␣ suggest the alternative possibility that the reduced phosphorylation of p38␣-K54R may be actually due to less efficient phosphorylation by MKK6.
A plausible explanation for our results is that the different MKK6 mutants behave as a gradient of MKK6 kinase activity: from an inactive kinase (MKK6-D/A) to maximum kinase activity (MKK6-DD). According to this interpretation, different levels of MKK6 activity would be required to activate the downstream p38 MAPKs; low levels would only activate p38␣, whereas high levels are able to activate both p38␣ and p38␥. We confirmed this hypothesis by titration of increasing amounts of MKK6-DD; whereas the phosphorylation and activation of p38␥ is proportional to the amount (and therefore the activity) of MKK6-DD, p38␣ is maximally activated with the lowest MKK6-DD concentrations. We also found that p38␤2 and p38␦ behave similarly to p38␥ in their susceptibility to activation by MKK6.
By constructing chimeras between p38␣ and p38␥, we have identified the carboxyl-terminal lobe of p38␣ as the region required for the efficient phosphorylation and activation by low levels of MKK6. However, the molecular determinants for this 2 G. Alonso and A. R. Nebreda, unpublished observations. selectivity do not appear to correspond to the activation loop and common docking sequences previously reported to be important for the efficient and/or selective activation of some MAPKs. Further mutagenesis analysis will be required to identify more precisely the sequences responsible for the differential activation of p38 isoforms by MKK6.
We have used different cell lines to provide evidence for the differential activation of MKK6 in response to different extracellular stimuli. We also found that different levels of endogenous MKK6 activity correlate with different ratios of activation of p38␣ versus other p38 isoforms (probably p38␥). However, it is important to keep in mind that the pattern of p38 isoforms being activated in a particular cellular response will not be determined only by the levels of MKK6 activity. Additional factors to be considered are the activation of other p38 MAPK kinases and the concentrations of both the p38 MAPKs and their activators, which are likely to be different depending on the cell type.
In summary, the preferential activation of certain p38 MAPKs by the MAPK kinases MKK3, MKK4, and MKK6 together with our finding that not all p38 MAPK isoforms require the same concentration of MKK6 for activation may have important implications for the regulation of the specificity in p38 MAPK signaling. Thus, the cellular response to a given stimulus could be determined by the subset of MAPK kinases being activated but also by the level of activation of the MAPK kinases that may cause the selective activation of one or more p38 MAPK isoforms. This may be regulated by the stability of the complexes between MAPK kinases and the p38 MAPKs, which might be an important factor in the case where limited amounts of activator are available.
